Nilufer Tampal

Statistics

Publications

Citations

651

H-Index

Active since

2001

Affiliations

United States Food and Drug Administration(Current)

Pfizer (United States)

Bristol-Myers Squibb (United States)

Health Canada

GlaxoSmithKline (United States)

Nilufer Tampal is an author at United States Food and Drug Administration specializing in pharmacy, clinical bioanalysis, and bioanalytical method validation.

Publications per year

2001–2021

Publications

Glucuronidation of Hydroxylated Polychlorinated Biphenyls (PCBs)

Nilufer Tampal, Hans‐Joachim Lehmler, Parvaneh Espandiari et al. · Chemical Research in Toxicology · 2002 · 78 citations

Pharmacy, Biochemistry, Toxicology +17

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)

Lakshmi Amaravadi, An Song, Heather Myler et al. · Bioanalysis · 2015 · 74 citations · Full text

Pharmacy, Biomedical Sciences, Pharmaceutical Analysis +16

2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assay Performance (Part 3 – Lba: Immunogenicity, Biomarkers and PK Assays)

Shalini Gupta, Susan Richards, Lakshmi Amaravadi et al. · Bioanalysis · 2017 · 67 citations · Full text

Pharmacy, Biomedical Sciences, Biopharmaceutics +16

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies)

Brad Ackermann, Hendrik Neubert, Nicola Hughes et al. · Bioanalysis · 2015 · 55 citations · Full text

Pharmacy, Biomedical Sciences, Pharmaceutical Analysis +17

2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV) (Part 1 – Small Molecules, Peptides and Small Molecule Biomarkers by LCMS)

Eric Yang, Jan Welink, Stephanie Cape et al. · Bioanalysis · 2016 · 48 citations · Full text

Pharmacy, Biochemistry, Biomedical Sciences +17

1–5 of 16